gfy personal page - To The Moon

gfy

gfy

No personal profile

22Follow

4Followers

0Topic

0Badge

2021-09-21

there is always a need for healthy correction, don't u think so?

Market sell-off worsens with Dow dropping 650 points, S&P 500 losing 2%

08-07

$SUPER MICRO COMPUTER INC(SMCI)$ the swing in price is definitely not for the faint- hearted

02-21

$NVIDIA Corp(NVDA)$ AI is just starting, the potential is still at its infancy

2021-09-20

interest seems like going to rise

Futures fall over 1% on growth worries, focus turns to Fed

01-04

Thanks for the opportunity to get richer in the new year!

2021-12-31

Unlike Uber and Gojek, Grab does not have the first-mover advantage, wouldn't you agree?

Grab stock climbed more than 3% in premarket trading

2021-12-31

Nice analysis! Unfortunately all of us can only wish we had a crystal ball, right?

If You Invested $10,000 in Novavax in 2020, This Is How Much You Would Have Today

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3585907907201082","uuid":"3585907907201082","gmtCreate":1622813959033,"gmtModify":1704447502103,"name":"gfy","pinyin":"gfy","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/5a74f7299f0be4bc2af3a318ef1e85c4","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":4,"headSize":22,"tweetSize":9,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":2,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"44212b71d0be4ec88898348dbe882e03-3","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"President Tiger","description":"The transaction amount of the securities account reaches $1,000,000","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.04.26","exceedPercentage":"93.11%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.03.01","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.11.28","exceedPercentage":"93.76%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.04.06","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.29","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":6,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":16,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":335653259452592,"gmtCreate":1722982685495,"gmtModify":1722982689393,"author":{"id":"3585907907201082","authorId":"3585907907201082","name":"gfy","avatar":"https://static.tigerbbs.com/5a74f7299f0be4bc2af3a318ef1e85c4","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585907907201082","authorIdStr":"3585907907201082"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/SMCI\">$SUPER MICRO COMPUTER INC(SMCI)$ </a> the swing in price is definitely not for the faint- hearted","listText":"<a href=\"https://ttm.financial/S/SMCI\">$SUPER MICRO COMPUTER INC(SMCI)$ </a> the swing in price is definitely not for the faint- hearted","text":"$SUPER MICRO COMPUTER INC(SMCI)$ the swing in price is definitely not for the faint- hearted","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/335653259452592","isVote":1,"tweetType":1,"viewCount":270,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":276471951421464,"gmtCreate":1708528361605,"gmtModify":1708528365063,"author":{"id":"3585907907201082","authorId":"3585907907201082","name":"gfy","avatar":"https://static.tigerbbs.com/5a74f7299f0be4bc2af3a318ef1e85c4","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585907907201082","authorIdStr":"3585907907201082"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA Corp(NVDA)$&nbsp;</a><v-v data-views=\"1\"></v-v> &nbsp;AI is just starting, the potential is still at its infancy","listText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA Corp(NVDA)$&nbsp;</a><v-v data-views=\"1\"></v-v> &nbsp;AI is just starting, the potential is still at its infancy","text":"$NVIDIA Corp(NVDA)$ AI is just starting, the potential is still at its infancy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/276471951421464","isVote":1,"tweetType":1,"viewCount":389,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":259550668578984,"gmtCreate":1704377401513,"gmtModify":1704377405467,"author":{"id":"3585907907201082","authorId":"3585907907201082","name":"gfy","avatar":"https://static.tigerbbs.com/5a74f7299f0be4bc2af3a318ef1e85c4","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585907907201082","authorIdStr":"3585907907201082"},"themes":[],"htmlText":"Thanks for the opportunity to get richer in the new year!","listText":"Thanks for the opportunity to get richer in the new year!","text":"Thanks for the opportunity to get richer in the new year!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/259550668578984","isVote":1,"tweetType":1,"viewCount":110,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9003839874,"gmtCreate":1640920770106,"gmtModify":1676533555414,"author":{"id":"3585907907201082","authorId":"3585907907201082","name":"gfy","avatar":"https://static.tigerbbs.com/5a74f7299f0be4bc2af3a318ef1e85c4","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585907907201082","authorIdStr":"3585907907201082"},"themes":[],"htmlText":"Unlike Uber and Gojek, Grab does not have the first-mover advantage, wouldn't&nbsp; you agree?","listText":"Unlike Uber and Gojek, Grab does not have the first-mover advantage, wouldn't&nbsp; you agree?","text":"Unlike Uber and Gojek, Grab does not have the first-mover advantage, wouldn't you agree?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9003839874","repostId":"1122789395","repostType":2,"repost":{"id":"1122789395","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640682350,"share":"https://ttm.financial/m/news/1122789395?lang=&edition=fundamental","pubTime":"2021-12-28 17:05","market":"us","language":"en","title":"Grab stock climbed more than 3% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1122789395","media":"Tiger Newspress","summary":"Grab stock climbed more than 3% in premarket trading Tuesday after falling more than 3% yesterday.\n\n","content":"<p>Grab stock climbed more than 3% in premarket trading&nbsp;Tuesday&nbsp;after falling more than 3% yesterday.</p>\n<p><img src=\"https://static.tigerbbs.com/7dfb400a3587d9cc0fba919a211e18a3\" tg-width=\"841\" tg-height=\"618\" referrerpolicy=\"no-referrer\"></p>\n<p>Grab debuted on the Nasdaq following a deal with blank-check company&nbsp;Altimeter Growth Corp., which&nbsp;valued the company at nearly $40 billion. It became the largest-ever company to close a SPAC merger and go public.</p>\n<p>But shares fell more than 20% from $13.06 to $8.75 a piece in the first day of trading. Since then, the stock has fallen another 16%.</p>\n<p>Still, JPMorgan likes the stock and said the company has a “superior regional superapp” and multiple opportunities for “multi-year growth.” The investment bank said that Grab’s regional leadership in Southeast Asia is driven by a highly scalable and localized platform that is underpinned by its proprietary technology.</p>\n<p>“The platform enables Grab to offer its services at a structurally lower cost base vs peers, with higher retention rates,” JPMorgan analysts wrote in their initiation coverage note earlier this month. “Grab’s platform gives it further advantages over its peers with limited geographical presence and/or fewer services, as Grab can allocate cash flows across countries and services to deliver on growth.”</p>\n<p>Here are JPMorgan, Citi and Evercore’s ratings and price targets for Grab, and why they like the stock:</p>\n<p><b>JPMorgan</b></p>\n<p>JPMorgan initiated coverage on Grab with an overweight rating and a price target of $12.50 over the next 12 months — that represents over 70% upside from the Dec. 23 closing price of $7.35.</p>\n<p>Based on the investment bank’s rating system, an overweight rating implies JPMorgan expects Grab’s stock to outperform over the next six to 12 months.</p>\n<p>The analysts said Grab’s superior regional app, comprising multiple services including ride-hailing and food delivery, is “best geared to rising online consumption” in Southeast Asia. They said they identified gross merchandize value and revenue growth as key catalysts for the company and they see “multiple opportunities for multi-year growth.”</p>\n<p>GMV is a metric&nbsp;often used in e-commerce&nbsp;to measure the total dollar value of goods sold&nbsp;over a certain period of time.</p>\n<p>The investment bank said Grab is a leader in ride-hailing across the region and that could lead to a highly profitable mobility business, where lifting Covid restrictions and broader economic reopening could drive growth.</p>\n<p>While the company’s delivery business is at an earlier stage of development, JPMorgan said there’s growth potential due to the relatively fragmented, but large total addressable market for food delivery and groceries. But the bank said that Grab is likely to see losses in the near-to-mid term due to investments and competition for market share.</p>\n<p>The analysts warned, however, that Grab’s stock price could be volatile over the next six months as the free float expands due to staggered expiration of lock-ups that will release additional shares. Potential inclusion in MSCI indexes could also contribute to the volatility, JPMorgan said.</p>\n<p><b>Citi</b></p>\n<p>Citi initiated coverage of Grab with a buy rating and a price target of $12 a share, but also flagged the stock as high risk.</p>\n<p>Compared with regional peers, Citi analysts said Grab benefits from its ability to capture larger volumes of consumer data given higher frequency of delivery and mobility demand compared to services like e-commerce. That gives the company an easier way to cross-sell its financial services products, they added.</p>\n<p>The analysts pointed out that Grab has a “broader geographic footprint with more equal strength in the ... Southeast Asia countries in which it operates,” compared with Indonesian rival GoTo Group.</p>\n<p>Citi said, however, spending per transaction and per user is lower for Grab than other regional players like&nbsp;Sea, which operates e-commerce platform Shopee. That implies Grab would face more headwinds if Covid cases in the region surge again, forcing countries to impose lockdowns and other mobility restrictions.</p>\n<p>“Grab also lacks a high-margin gaming business and global exposure given its Southeast Asia focus,” Citi analysts said.</p>\n<p><b>Evercore</b></p>\n<p>Evercore initiated coverage with an outperform rating and a price target of $10.</p>\n<p>The firm said Grab will likely face more local competition in each market for its delivery business compared to ridesharing, where the only other international incumbent is GoTo Group’s Gojek — particularly, in Indonesia.</p>\n<p>“Within its Delivery segment, Grab faces a bit more competition across its core geographies,” Evercore analysts said in a recent note. They flagged the likes of Foodpanda, Gojek and Deliveroo in Singapore, LineMan in Thailand as well as Now and Baemin in Vietnam as competitors.</p>\n<p>“Lastly, Grab competes with last-mile logistics providers such as Gojek and Lalamove, and more local last-mile players such as AhaMove (Vietnam),” the analysts said.</p>\n<p>In the financial services business, Grab faces competition from traditional players including credit card companies, banks as well as cash, which is still the predominant mode of payment in Southeast Asia.</p>\n<p>Still, the Evercore analysts said that most of Grab’s core business segments including delivery, mobility and financial services remain underpenetrated, which grants the Singapore-headquartered company “a probable long runway for growth.”</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Grab stock climbed more than 3% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGrab stock climbed more than 3% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-28 17:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Grab stock climbed more than 3% in premarket trading&nbsp;Tuesday&nbsp;after falling more than 3% yesterday.</p>\n<p><img src=\"https://static.tigerbbs.com/7dfb400a3587d9cc0fba919a211e18a3\" tg-width=\"841\" tg-height=\"618\" referrerpolicy=\"no-referrer\"></p>\n<p>Grab debuted on the Nasdaq following a deal with blank-check company&nbsp;Altimeter Growth Corp., which&nbsp;valued the company at nearly $40 billion. It became the largest-ever company to close a SPAC merger and go public.</p>\n<p>But shares fell more than 20% from $13.06 to $8.75 a piece in the first day of trading. Since then, the stock has fallen another 16%.</p>\n<p>Still, JPMorgan likes the stock and said the company has a “superior regional superapp” and multiple opportunities for “multi-year growth.” The investment bank said that Grab’s regional leadership in Southeast Asia is driven by a highly scalable and localized platform that is underpinned by its proprietary technology.</p>\n<p>“The platform enables Grab to offer its services at a structurally lower cost base vs peers, with higher retention rates,” JPMorgan analysts wrote in their initiation coverage note earlier this month. “Grab’s platform gives it further advantages over its peers with limited geographical presence and/or fewer services, as Grab can allocate cash flows across countries and services to deliver on growth.”</p>\n<p>Here are JPMorgan, Citi and Evercore’s ratings and price targets for Grab, and why they like the stock:</p>\n<p><b>JPMorgan</b></p>\n<p>JPMorgan initiated coverage on Grab with an overweight rating and a price target of $12.50 over the next 12 months — that represents over 70% upside from the Dec. 23 closing price of $7.35.</p>\n<p>Based on the investment bank’s rating system, an overweight rating implies JPMorgan expects Grab’s stock to outperform over the next six to 12 months.</p>\n<p>The analysts said Grab’s superior regional app, comprising multiple services including ride-hailing and food delivery, is “best geared to rising online consumption” in Southeast Asia. They said they identified gross merchandize value and revenue growth as key catalysts for the company and they see “multiple opportunities for multi-year growth.”</p>\n<p>GMV is a metric&nbsp;often used in e-commerce&nbsp;to measure the total dollar value of goods sold&nbsp;over a certain period of time.</p>\n<p>The investment bank said Grab is a leader in ride-hailing across the region and that could lead to a highly profitable mobility business, where lifting Covid restrictions and broader economic reopening could drive growth.</p>\n<p>While the company’s delivery business is at an earlier stage of development, JPMorgan said there’s growth potential due to the relatively fragmented, but large total addressable market for food delivery and groceries. But the bank said that Grab is likely to see losses in the near-to-mid term due to investments and competition for market share.</p>\n<p>The analysts warned, however, that Grab’s stock price could be volatile over the next six months as the free float expands due to staggered expiration of lock-ups that will release additional shares. Potential inclusion in MSCI indexes could also contribute to the volatility, JPMorgan said.</p>\n<p><b>Citi</b></p>\n<p>Citi initiated coverage of Grab with a buy rating and a price target of $12 a share, but also flagged the stock as high risk.</p>\n<p>Compared with regional peers, Citi analysts said Grab benefits from its ability to capture larger volumes of consumer data given higher frequency of delivery and mobility demand compared to services like e-commerce. That gives the company an easier way to cross-sell its financial services products, they added.</p>\n<p>The analysts pointed out that Grab has a “broader geographic footprint with more equal strength in the ... Southeast Asia countries in which it operates,” compared with Indonesian rival GoTo Group.</p>\n<p>Citi said, however, spending per transaction and per user is lower for Grab than other regional players like&nbsp;Sea, which operates e-commerce platform Shopee. That implies Grab would face more headwinds if Covid cases in the region surge again, forcing countries to impose lockdowns and other mobility restrictions.</p>\n<p>“Grab also lacks a high-margin gaming business and global exposure given its Southeast Asia focus,” Citi analysts said.</p>\n<p><b>Evercore</b></p>\n<p>Evercore initiated coverage with an outperform rating and a price target of $10.</p>\n<p>The firm said Grab will likely face more local competition in each market for its delivery business compared to ridesharing, where the only other international incumbent is GoTo Group’s Gojek — particularly, in Indonesia.</p>\n<p>“Within its Delivery segment, Grab faces a bit more competition across its core geographies,” Evercore analysts said in a recent note. They flagged the likes of Foodpanda, Gojek and Deliveroo in Singapore, LineMan in Thailand as well as Now and Baemin in Vietnam as competitors.</p>\n<p>“Lastly, Grab competes with last-mile logistics providers such as Gojek and Lalamove, and more local last-mile players such as AhaMove (Vietnam),” the analysts said.</p>\n<p>In the financial services business, Grab faces competition from traditional players including credit card companies, banks as well as cash, which is still the predominant mode of payment in Southeast Asia.</p>\n<p>Still, the Evercore analysts said that most of Grab’s core business segments including delivery, mobility and financial services remain underpenetrated, which grants the Singapore-headquartered company “a probable long runway for growth.”</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GRAB":"Grab Holdings"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1122789395","content_text":"Grab stock climbed more than 3% in premarket trading Tuesday after falling more than 3% yesterday.\n\nGrab debuted on the Nasdaq following a deal with blank-check company Altimeter Growth Corp., which valued the company at nearly $40 billion. It became the largest-ever company to close a SPAC merger and go public.\nBut shares fell more than 20% from $13.06 to $8.75 a piece in the first day of trading. Since then, the stock has fallen another 16%.\nStill, JPMorgan likes the stock and said the company has a “superior regional superapp” and multiple opportunities for “multi-year growth.” The investment bank said that Grab’s regional leadership in Southeast Asia is driven by a highly scalable and localized platform that is underpinned by its proprietary technology.\n“The platform enables Grab to offer its services at a structurally lower cost base vs peers, with higher retention rates,” JPMorgan analysts wrote in their initiation coverage note earlier this month. “Grab’s platform gives it further advantages over its peers with limited geographical presence and/or fewer services, as Grab can allocate cash flows across countries and services to deliver on growth.”\nHere are JPMorgan, Citi and Evercore’s ratings and price targets for Grab, and why they like the stock:\nJPMorgan\nJPMorgan initiated coverage on Grab with an overweight rating and a price target of $12.50 over the next 12 months — that represents over 70% upside from the Dec. 23 closing price of $7.35.\nBased on the investment bank’s rating system, an overweight rating implies JPMorgan expects Grab’s stock to outperform over the next six to 12 months.\nThe analysts said Grab’s superior regional app, comprising multiple services including ride-hailing and food delivery, is “best geared to rising online consumption” in Southeast Asia. They said they identified gross merchandize value and revenue growth as key catalysts for the company and they see “multiple opportunities for multi-year growth.”\nGMV is a metric often used in e-commerce to measure the total dollar value of goods sold over a certain period of time.\nThe investment bank said Grab is a leader in ride-hailing across the region and that could lead to a highly profitable mobility business, where lifting Covid restrictions and broader economic reopening could drive growth.\nWhile the company’s delivery business is at an earlier stage of development, JPMorgan said there’s growth potential due to the relatively fragmented, but large total addressable market for food delivery and groceries. But the bank said that Grab is likely to see losses in the near-to-mid term due to investments and competition for market share.\nThe analysts warned, however, that Grab’s stock price could be volatile over the next six months as the free float expands due to staggered expiration of lock-ups that will release additional shares. Potential inclusion in MSCI indexes could also contribute to the volatility, JPMorgan said.\nCiti\nCiti initiated coverage of Grab with a buy rating and a price target of $12 a share, but also flagged the stock as high risk.\nCompared with regional peers, Citi analysts said Grab benefits from its ability to capture larger volumes of consumer data given higher frequency of delivery and mobility demand compared to services like e-commerce. That gives the company an easier way to cross-sell its financial services products, they added.\nThe analysts pointed out that Grab has a “broader geographic footprint with more equal strength in the ... Southeast Asia countries in which it operates,” compared with Indonesian rival GoTo Group.\nCiti said, however, spending per transaction and per user is lower for Grab than other regional players like Sea, which operates e-commerce platform Shopee. That implies Grab would face more headwinds if Covid cases in the region surge again, forcing countries to impose lockdowns and other mobility restrictions.\n“Grab also lacks a high-margin gaming business and global exposure given its Southeast Asia focus,” Citi analysts said.\nEvercore\nEvercore initiated coverage with an outperform rating and a price target of $10.\nThe firm said Grab will likely face more local competition in each market for its delivery business compared to ridesharing, where the only other international incumbent is GoTo Group’s Gojek — particularly, in Indonesia.\n“Within its Delivery segment, Grab faces a bit more competition across its core geographies,” Evercore analysts said in a recent note. They flagged the likes of Foodpanda, Gojek and Deliveroo in Singapore, LineMan in Thailand as well as Now and Baemin in Vietnam as competitors.\n“Lastly, Grab competes with last-mile logistics providers such as Gojek and Lalamove, and more local last-mile players such as AhaMove (Vietnam),” the analysts said.\nIn the financial services business, Grab faces competition from traditional players including credit card companies, banks as well as cash, which is still the predominant mode of payment in Southeast Asia.\nStill, the Evercore analysts said that most of Grab’s core business segments including delivery, mobility and financial services remain underpenetrated, which grants the Singapore-headquartered company “a probable long runway for growth.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":480,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9003897561,"gmtCreate":1640920473781,"gmtModify":1676533555373,"author":{"id":"3585907907201082","authorId":"3585907907201082","name":"gfy","avatar":"https://static.tigerbbs.com/5a74f7299f0be4bc2af3a318ef1e85c4","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585907907201082","authorIdStr":"3585907907201082"},"themes":[],"htmlText":"Nice analysis! Unfortunately all of us can only wish we had a crystal ball, right?","listText":"Nice analysis! Unfortunately all of us can only wish we had a crystal ball, right?","text":"Nice analysis! Unfortunately all of us can only wish we had a crystal ball, right?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9003897561","repostId":"2195932414","repostType":2,"repost":{"id":"2195932414","pubTimestamp":1640793600,"share":"https://ttm.financial/m/news/2195932414?lang=&edition=fundamental","pubTime":"2021-12-30 00:00","market":"us","language":"en","title":"If You Invested $10,000 in Novavax in 2020, This Is How Much You Would Have Today","url":"https://stock-news.laohu8.com/highlight/detail?id=2195932414","media":"Motley Fool","summary":"Your returns could range between a loss and more than 3,000% depending on which month you invested in.","content":"<html><body><span>\n<p><strong>Novavax </strong><span>(NASDAQ:NVAX)</span> has been a volatile stock over the past few years. From optimism around its COVID-19 vaccine to concerns about delays, it has sent its investors on a roller-coaster ride. Early investors are sitting on some incredible returns right now, but those who bought early on this year when the stock was trading at more than $300 have incurred steep losses.</p>\n<p>I'll look back at how you would have done in 2020 if you had bought at different months, and how early you would have needed to get in on the stock to earn a great return. And, most importantly, I'll assess whether the stock worth buying today.</p>\n<div><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F658847%2Ftwo-scientists-reviewing-a-sample-in-a-tube.jpg&amp;w=700&amp;op=resize\" srcset=\"https://g.foolcdn.com/image/?url=https%3A//g.foolcdn.com/editorial/images/658847/two-scientists-reviewing-a-sample-in-a-tube.jpg&amp;w=300&amp;op=resize 300w, https://g.foolcdn.com/image/?url=https%3A//g.foolcdn.com/editorial/images/658847/two-scientists-reviewing-a-sample-in-a-tube.jpg&amp;w=1000&amp;op=resize 1000w, https://g.foolcdn.com/image/?url=https%3A//g.foolcdn.com/editorial/images/658847/two-scientists-reviewing-a-sample-in-a-tube.jpg&amp;w=2000&amp;op=resize 2000w\"/>\n<p>Image source: Getty Images</p>\n</div>\n<h2>How early would have been early enough in 2020?</h2>\n<p>Here's a look at Novavax's share price at the start of each month of 2020, how many shares you could have bought with a $10,000 investment, and what the value of it would be today. </p>\n<div><table width=\"426\">\n<thead>\n<tr>\n<th>Month</th>\n<th>Closing Price</th>\n<th>Shares Bought</th>\n<th>Approximate Value Today</th>\n<th>Return</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>January</td>\n<td>$4.49</td>\n<td>2,227.2</td>\n<td> $351,448</td>\n<td>3,414%</td>\n</tr>\n<tr>\n<td>February</td>\n<td>$6.81</td>\n<td>1,468.4</td>\n<td> $231,718</td>\n<td>2,217%</td>\n</tr>\n<tr>\n<td>March</td>\n<td>$12.02</td>\n<td>831.9</td>\n<td> $131,281</td>\n<td>1,213%</td>\n</tr>\n<tr>\n<td>April</td>\n<td>$14.03</td>\n<td>712.8</td>\n<td> $112,473</td>\n<td>1,025%</td>\n</tr>\n<tr>\n<td>May</td>\n<td>$17.33</td>\n<td>577.0</td>\n<td> $91,056</td>\n<td>811%</td>\n</tr>\n<tr>\n<td>June</td>\n<td>$52.82</td>\n<td>189.3</td>\n<td> $29,875</td>\n<td>199%</td>\n</tr>\n<tr>\n<td>July</td>\n<td>$79.70</td>\n<td>125.5</td>\n<td> $19,799</td>\n<td>98%</td>\n</tr>\n<tr>\n<td>August</td>\n<td>$155.87</td>\n<td>64.2</td>\n<td> $10,124</td>\n<td>1%</td>\n</tr>\n<tr>\n<td>September</td>\n<td>$105.08</td>\n<td>95.2</td>\n<td> $15,017</td>\n<td>50%</td>\n</tr>\n<tr>\n<td>October</td>\n<td>$104.90</td>\n<td>95.3</td>\n<td> $15,043</td>\n<td>50%</td>\n</tr>\n<tr>\n<td>November</td>\n<td>$82.40</td>\n<td>121.4</td>\n<td> $19,150</td>\n<td>92%</td>\n</tr>\n<tr>\n<td>December</td>\n<td>$123.47</td>\n<td>81.0</td>\n<td> $12,780</td>\n<td>28%</td>\n</tr>\n</tbody>\n</table></div>\n<p>Data source: Yahoo! Finance.</p>\n<p>Investing at the start of January would have netted the best return, at a whopping 3,414%. It was late February that the healthcare company announced it was advancing development of its COVID-19 vaccine and that phase 1 trials would commence in the coming months. If you had the foresight to bet on the company at that point, it would have been a tremendous gamble; it wasn't until March that the World Health Organization (WHO) even declared the coronavirus a pandemic. The company was also coming off a year in which it generated just $19 million in revenue (mainly through grants and government contracts) and incurred a loss of $133 million.</p><div></div>\n<p>April presented a more realistic time when the risk-reward ratio became more tenable. At that point, the pandemic was here and Novavax had announced the previous month that it would be receiving $4 million in funding from the Coalition for Epidemic Preparedness Innovations (CEPI) to help with the development of the vaccine. In May, CEPI would add another $384 million to that funding. Before the end of the month, the company enrolled its first participants in its phase 1/2 trial. By the start of June, shares were already up over $50. If you waited until then, your investment would have tripled in value.</p>\n<p>And if you waited until December, the stock would be up to $123. Later in the month, the U.S. Food and Drug Administration would issue Emergency Use Authorizations (EUAs) for vaccines from <strong>Pfizer</strong> and <strong>Moderna. </strong>The authorization for <strong>Johnson &amp; Johnson</strong>'s vaccine would come in February 2021. </p>\n<h2>Is Novavax a good buy today?</h2>\n<p>It has been more than a year since the EUAs came in for Moderna and Pfizer's vaccines. More than 60% of the U.S. population is fully vaccinated and many people are on their way to receiving their booster shots. Novavax could apply for an EUA any day now, and investors may be getting unnerved by the lack of progress and constant delays. </p>\n<p>But even if it doesn't obtain an EUA in the U.S., there's arguably much more of a need to fill in other parts of the world, especially in countries where vaccination rates are significantly lower. The downside is that Novavax might not fetch as high a price for its vaccine, but it would still generate revenue nonetheless. In November, Novavax received EUAs from the Philippines and Indonesia for its vaccine, and it has applied for approvals in other countries as well. On Dec. 17, the World Health Organization added the vaccine to its Emergency Use Listing, potentially paving the way for Novavax's vaccine to get exported to even more countries.</p><div></div>\n<p>It's safe to say that Novavax will generate COVID-19-related revenue, but whether it will be enough to support its current valuation is the bigger question at this point. At a forward price-to-sales (P/S) multiple of more than eight, it's priced higher than the other vaccine makers mentioned earlier:</p>\n<p><img src=\"https://media.ycharts.com/charts/b277bae638c59f4fa45bd391dcd8f9c7.png\"/></p>\n<p>NVAX PS Ratio (Forward) data by YCharts</p>\n<p>Novavax has taken a long time to get to where it is today, which is well behind the leaders in the COVID-19 vaccine market at this point. And based on that track record, I wouldn't take a chance on a stock that has created a bit of reputation for delays and disappointing investors. At this stage, there may be more risk than there is reward, and that's why I'd avoid Novavax stock for now.</p>\n<div></div>\n</span></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>If You Invested $10,000 in Novavax in 2020, This Is How Much You Would Have Today</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIf You Invested $10,000 in Novavax in 2020, This Is How Much You Would Have Today\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-30 00:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/30/if-you-invested-10000-in-novavax-in-2020-this-is-h/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Novavax (NASDAQ:NVAX) has been a volatile stock over the past few years. From optimism around its COVID-19 vaccine to concerns about delays, it has sent its investors on a roller-coaster ride. Early ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/30/if-you-invested-10000-in-novavax-in-2020-this-is-h/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药","BK4568":"美国抗疫概念","BK4139":"生物科技"},"source_url":"https://www.fool.com/investing/2021/12/30/if-you-invested-10000-in-novavax-in-2020-this-is-h/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2195932414","content_text":"Novavax (NASDAQ:NVAX) has been a volatile stock over the past few years. From optimism around its COVID-19 vaccine to concerns about delays, it has sent its investors on a roller-coaster ride. Early investors are sitting on some incredible returns right now, but those who bought early on this year when the stock was trading at more than $300 have incurred steep losses.\nI'll look back at how you would have done in 2020 if you had bought at different months, and how early you would have needed to get in on the stock to earn a great return. And, most importantly, I'll assess whether the stock worth buying today.\n\nImage source: Getty Images\n\nHow early would have been early enough in 2020?\nHere's a look at Novavax's share price at the start of each month of 2020, how many shares you could have bought with a $10,000 investment, and what the value of it would be today. \n\n\n\nMonth\nClosing Price\nShares Bought\nApproximate Value Today\nReturn\n\n\n\n\nJanuary\n$4.49\n2,227.2\n $351,448\n3,414%\n\n\nFebruary\n$6.81\n1,468.4\n $231,718\n2,217%\n\n\nMarch\n$12.02\n831.9\n $131,281\n1,213%\n\n\nApril\n$14.03\n712.8\n $112,473\n1,025%\n\n\nMay\n$17.33\n577.0\n $91,056\n811%\n\n\nJune\n$52.82\n189.3\n $29,875\n199%\n\n\nJuly\n$79.70\n125.5\n $19,799\n98%\n\n\nAugust\n$155.87\n64.2\n $10,124\n1%\n\n\nSeptember\n$105.08\n95.2\n $15,017\n50%\n\n\nOctober\n$104.90\n95.3\n $15,043\n50%\n\n\nNovember\n$82.40\n121.4\n $19,150\n92%\n\n\nDecember\n$123.47\n81.0\n $12,780\n28%\n\n\n\nData source: Yahoo! Finance.\nInvesting at the start of January would have netted the best return, at a whopping 3,414%. It was late February that the healthcare company announced it was advancing development of its COVID-19 vaccine and that phase 1 trials would commence in the coming months. If you had the foresight to bet on the company at that point, it would have been a tremendous gamble; it wasn't until March that the World Health Organization (WHO) even declared the coronavirus a pandemic. The company was also coming off a year in which it generated just $19 million in revenue (mainly through grants and government contracts) and incurred a loss of $133 million.\nApril presented a more realistic time when the risk-reward ratio became more tenable. At that point, the pandemic was here and Novavax had announced the previous month that it would be receiving $4 million in funding from the Coalition for Epidemic Preparedness Innovations (CEPI) to help with the development of the vaccine. In May, CEPI would add another $384 million to that funding. Before the end of the month, the company enrolled its first participants in its phase 1/2 trial. By the start of June, shares were already up over $50. If you waited until then, your investment would have tripled in value.\nAnd if you waited until December, the stock would be up to $123. Later in the month, the U.S. Food and Drug Administration would issue Emergency Use Authorizations (EUAs) for vaccines from Pfizer and Moderna. The authorization for Johnson & Johnson's vaccine would come in February 2021. \nIs Novavax a good buy today?\nIt has been more than a year since the EUAs came in for Moderna and Pfizer's vaccines. More than 60% of the U.S. population is fully vaccinated and many people are on their way to receiving their booster shots. Novavax could apply for an EUA any day now, and investors may be getting unnerved by the lack of progress and constant delays. \nBut even if it doesn't obtain an EUA in the U.S., there's arguably much more of a need to fill in other parts of the world, especially in countries where vaccination rates are significantly lower. The downside is that Novavax might not fetch as high a price for its vaccine, but it would still generate revenue nonetheless. In November, Novavax received EUAs from the Philippines and Indonesia for its vaccine, and it has applied for approvals in other countries as well. On Dec. 17, the World Health Organization added the vaccine to its Emergency Use Listing, potentially paving the way for Novavax's vaccine to get exported to even more countries.\nIt's safe to say that Novavax will generate COVID-19-related revenue, but whether it will be enough to support its current valuation is the bigger question at this point. At a forward price-to-sales (P/S) multiple of more than eight, it's priced higher than the other vaccine makers mentioned earlier:\n\nNVAX PS Ratio (Forward) data by YCharts\nNovavax has taken a long time to get to where it is today, which is well behind the leaders in the COVID-19 vaccine market at this point. And based on that track record, I wouldn't take a chance on a stock that has created a bit of reputation for delays and disappointing investors. At this stage, there may be more risk than there is reward, and that's why I'd avoid Novavax stock for now.","news_type":1},"isVote":1,"tweetType":1,"viewCount":327,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":860642449,"gmtCreate":1632179454781,"gmtModify":1676530716916,"author":{"id":"3585907907201082","authorId":"3585907907201082","name":"gfy","avatar":"https://static.tigerbbs.com/5a74f7299f0be4bc2af3a318ef1e85c4","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585907907201082","authorIdStr":"3585907907201082"},"themes":[],"htmlText":"there is always a need for&nbsp;healthy correction, don't u think so?","listText":"there is always a need for&nbsp;healthy correction, don't u think so?","text":"there is always a need for healthy correction, don't u think so?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/860642449","repostId":"1124728794","repostType":4,"repost":{"id":"1124728794","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1632154404,"share":"https://ttm.financial/m/news/1124728794?lang=&edition=fundamental","pubTime":"2021-09-21 00:13","market":"other","language":"en","title":"Market sell-off worsens with Dow dropping 650 points, S&P 500 losing 2%","url":"https://stock-news.laohu8.com/highlight/detail?id=1124728794","media":"Tiger Newspress","summary":"(Sept 21)&nbsp;Market sell-off worsens with Dow dropping 650 points, S&P 500 losing 2%.","content":"<p>(Sept 21)&nbsp;Market sell-off worsens with Dow dropping 650 points, S&amp;P 500 losing 2%.</p>\n<p><img src=\"https://static.tigerbbs.com/b1aff42b5f28f13e23dc15c6bee909d3\" tg-width=\"350\" tg-height=\"130\" width=\"100%\" height=\"auto\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Market sell-off worsens with Dow dropping 650 points, S&P 500 losing 2%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMarket sell-off worsens with Dow dropping 650 points, S&P 500 losing 2%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-09-21 00:13</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(Sept 21)&nbsp;Market sell-off worsens with Dow dropping 650 points, S&amp;P 500 losing 2%.</p>\n<p><img src=\"https://static.tigerbbs.com/b1aff42b5f28f13e23dc15c6bee909d3\" tg-width=\"350\" tg-height=\"130\" width=\"100%\" height=\"auto\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1124728794","content_text":"(Sept 21) Market sell-off worsens with Dow dropping 650 points, S&P 500 losing 2%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":185,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":860391947,"gmtCreate":1632131363289,"gmtModify":1676530706958,"author":{"id":"3585907907201082","authorId":"3585907907201082","name":"gfy","avatar":"https://static.tigerbbs.com/5a74f7299f0be4bc2af3a318ef1e85c4","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585907907201082","authorIdStr":"3585907907201082"},"themes":[],"htmlText":"interest seems like going to rise","listText":"interest seems like going to rise","text":"interest seems like going to rise","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/860391947","repostId":"1190902808","repostType":4,"repost":{"id":"1190902808","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1632128652,"share":"https://ttm.financial/m/news/1190902808?lang=&edition=fundamental","pubTime":"2021-09-20 17:04","market":"us","language":"en","title":"Futures fall over 1% on growth worries, focus turns to Fed","url":"https://stock-news.laohu8.com/highlight/detail?id=1190902808","media":"Reuters","summary":"Futures off: Dow 1.46%, S&P 1.23%, Nasdaq 1.05%.\n\nSept 20 (Reuters) - U.S. stock index futures fell ","content":"<ul>\n <li>Futures off: Dow 1.46%, S&amp;P 1.23%, Nasdaq 1.05%.</li>\n</ul>\n<p>Sept 20 (Reuters) - U.S. stock index futures fell 1% on Monday, as investors worried about rising COVID-19 cases and the pace of economic growth at the start of a week in which the Federal Reserve will decide on potentially tapering its massive pandemic-era stimulus.</p>\n<p>Futures tracking the blue-chip Dow index, which mainly comprises stocks reliant on a steady economic recovery, were down 1.5% by 04:31 a.m. ET.</p>\n<p>Wall Street's main indexes have been hurt this month by fears of potentially higher corporate tax rates denting earnings and have shrugged off signs inflation might have peaked. The benchmark S&amp;P 500 is on track to snap a seven-month gaining streak.</p>\n<p>All eyes on Wednesday will be on the Fed's policy meeting, where the central bank is expected to lay the groundwork for a tapering, although the consensus is for an actual announcement to be delayed until the November or December meetings.</p>\n<p>\"Anything pointing to a November tapering decision may support the U.S. dollar further and perhaps extend the latest setback in equities,\" said Charalambos Pissouros, head of research at JFD Group.</p>\n<p>\"Market participants may also be eager to find out whether this could also result in earlier rate hikes.\"</p>\n<p>Global equity markets have also been on edge recently over deepening troubles at China Evergrande, the world's most indebted property developer.</p>\n<p>Its shares sank more than 15% on Monday on worries about its ability to repay a small portion of its $305 billion debt due this Thursday.</p>\n<p>In the United States, S&amp;P 500 e-minis were down 1.23%, and Nasdaq 100 e-minis were down 1.05%.</p>\n<p>Economically sensitive industrials Boeing Co and Caterpillar Inc slipped 1.7% and 1.9%, respectively.</p>\n<p>Banking stocks including Morgan Stanley, JPMorgan Chase &amp; Co and Bank of America Corp fell between 1.8% and 2.7% in premarket trading, tracking U.S. Treasury yields.</p>\n<p>A slate of U.S.-listed Chinese stocks including Weibo Corp , Bilibili Inc, Vipshop Holdings Ltd and Pinduoduo Inc shed between 3.4% and 5.4% amid a widening regulatory crackdown in China.</p>\n<p>Heavyweight technology-related stocks , which have tended to perform better during times of economic uncertainty, were among the smallest decliners.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Futures fall over 1% on growth worries, focus turns to Fed</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFutures fall over 1% on growth worries, focus turns to Fed\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-09-20 17:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<ul>\n <li>Futures off: Dow 1.46%, S&amp;P 1.23%, Nasdaq 1.05%.</li>\n</ul>\n<p>Sept 20 (Reuters) - U.S. stock index futures fell 1% on Monday, as investors worried about rising COVID-19 cases and the pace of economic growth at the start of a week in which the Federal Reserve will decide on potentially tapering its massive pandemic-era stimulus.</p>\n<p>Futures tracking the blue-chip Dow index, which mainly comprises stocks reliant on a steady economic recovery, were down 1.5% by 04:31 a.m. ET.</p>\n<p>Wall Street's main indexes have been hurt this month by fears of potentially higher corporate tax rates denting earnings and have shrugged off signs inflation might have peaked. The benchmark S&amp;P 500 is on track to snap a seven-month gaining streak.</p>\n<p>All eyes on Wednesday will be on the Fed's policy meeting, where the central bank is expected to lay the groundwork for a tapering, although the consensus is for an actual announcement to be delayed until the November or December meetings.</p>\n<p>\"Anything pointing to a November tapering decision may support the U.S. dollar further and perhaps extend the latest setback in equities,\" said Charalambos Pissouros, head of research at JFD Group.</p>\n<p>\"Market participants may also be eager to find out whether this could also result in earlier rate hikes.\"</p>\n<p>Global equity markets have also been on edge recently over deepening troubles at China Evergrande, the world's most indebted property developer.</p>\n<p>Its shares sank more than 15% on Monday on worries about its ability to repay a small portion of its $305 billion debt due this Thursday.</p>\n<p>In the United States, S&amp;P 500 e-minis were down 1.23%, and Nasdaq 100 e-minis were down 1.05%.</p>\n<p>Economically sensitive industrials Boeing Co and Caterpillar Inc slipped 1.7% and 1.9%, respectively.</p>\n<p>Banking stocks including Morgan Stanley, JPMorgan Chase &amp; Co and Bank of America Corp fell between 1.8% and 2.7% in premarket trading, tracking U.S. Treasury yields.</p>\n<p>A slate of U.S.-listed Chinese stocks including Weibo Corp , Bilibili Inc, Vipshop Holdings Ltd and Pinduoduo Inc shed between 3.4% and 5.4% amid a widening regulatory crackdown in China.</p>\n<p>Heavyweight technology-related stocks , which have tended to perform better during times of economic uncertainty, were among the smallest decliners.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite","SPY":"标普500ETF",".DJI":"道琼斯",".SPX":"S&P 500 Index"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1190902808","content_text":"Futures off: Dow 1.46%, S&P 1.23%, Nasdaq 1.05%.\n\nSept 20 (Reuters) - U.S. stock index futures fell 1% on Monday, as investors worried about rising COVID-19 cases and the pace of economic growth at the start of a week in which the Federal Reserve will decide on potentially tapering its massive pandemic-era stimulus.\nFutures tracking the blue-chip Dow index, which mainly comprises stocks reliant on a steady economic recovery, were down 1.5% by 04:31 a.m. ET.\nWall Street's main indexes have been hurt this month by fears of potentially higher corporate tax rates denting earnings and have shrugged off signs inflation might have peaked. The benchmark S&P 500 is on track to snap a seven-month gaining streak.\nAll eyes on Wednesday will be on the Fed's policy meeting, where the central bank is expected to lay the groundwork for a tapering, although the consensus is for an actual announcement to be delayed until the November or December meetings.\n\"Anything pointing to a November tapering decision may support the U.S. dollar further and perhaps extend the latest setback in equities,\" said Charalambos Pissouros, head of research at JFD Group.\n\"Market participants may also be eager to find out whether this could also result in earlier rate hikes.\"\nGlobal equity markets have also been on edge recently over deepening troubles at China Evergrande, the world's most indebted property developer.\nIts shares sank more than 15% on Monday on worries about its ability to repay a small portion of its $305 billion debt due this Thursday.\nIn the United States, S&P 500 e-minis were down 1.23%, and Nasdaq 100 e-minis were down 1.05%.\nEconomically sensitive industrials Boeing Co and Caterpillar Inc slipped 1.7% and 1.9%, respectively.\nBanking stocks including Morgan Stanley, JPMorgan Chase & Co and Bank of America Corp fell between 1.8% and 2.7% in premarket trading, tracking U.S. Treasury yields.\nA slate of U.S.-listed Chinese stocks including Weibo Corp , Bilibili Inc, Vipshop Holdings Ltd and Pinduoduo Inc shed between 3.4% and 5.4% amid a widening regulatory crackdown in China.\nHeavyweight technology-related stocks , which have tended to perform better during times of economic uncertainty, were among the smallest decliners.","news_type":1},"isVote":1,"tweetType":1,"viewCount":402,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":860642449,"gmtCreate":1632179454781,"gmtModify":1676530716916,"author":{"id":"3585907907201082","authorId":"3585907907201082","name":"gfy","avatar":"https://static.tigerbbs.com/5a74f7299f0be4bc2af3a318ef1e85c4","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585907907201082","authorIdStr":"3585907907201082"},"themes":[],"htmlText":"there is always a need for&nbsp;healthy correction, don't u think so?","listText":"there is always a need for&nbsp;healthy correction, don't u think so?","text":"there is always a need for healthy correction, don't u think so?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/860642449","repostId":"1124728794","repostType":4,"repost":{"id":"1124728794","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1632154404,"share":"https://ttm.financial/m/news/1124728794?lang=&edition=fundamental","pubTime":"2021-09-21 00:13","market":"other","language":"en","title":"Market sell-off worsens with Dow dropping 650 points, S&P 500 losing 2%","url":"https://stock-news.laohu8.com/highlight/detail?id=1124728794","media":"Tiger Newspress","summary":"(Sept 21)&nbsp;Market sell-off worsens with Dow dropping 650 points, S&P 500 losing 2%.","content":"<p>(Sept 21)&nbsp;Market sell-off worsens with Dow dropping 650 points, S&amp;P 500 losing 2%.</p>\n<p><img src=\"https://static.tigerbbs.com/b1aff42b5f28f13e23dc15c6bee909d3\" tg-width=\"350\" tg-height=\"130\" width=\"100%\" height=\"auto\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Market sell-off worsens with Dow dropping 650 points, S&P 500 losing 2%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMarket sell-off worsens with Dow dropping 650 points, S&P 500 losing 2%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-09-21 00:13</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(Sept 21)&nbsp;Market sell-off worsens with Dow dropping 650 points, S&amp;P 500 losing 2%.</p>\n<p><img src=\"https://static.tigerbbs.com/b1aff42b5f28f13e23dc15c6bee909d3\" tg-width=\"350\" tg-height=\"130\" width=\"100%\" height=\"auto\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1124728794","content_text":"(Sept 21) Market sell-off worsens with Dow dropping 650 points, S&P 500 losing 2%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":185,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":335653259452592,"gmtCreate":1722982685495,"gmtModify":1722982689393,"author":{"id":"3585907907201082","authorId":"3585907907201082","name":"gfy","avatar":"https://static.tigerbbs.com/5a74f7299f0be4bc2af3a318ef1e85c4","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585907907201082","authorIdStr":"3585907907201082"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/SMCI\">$SUPER MICRO COMPUTER INC(SMCI)$ </a> the swing in price is definitely not for the faint- hearted","listText":"<a href=\"https://ttm.financial/S/SMCI\">$SUPER MICRO COMPUTER INC(SMCI)$ </a> the swing in price is definitely not for the faint- hearted","text":"$SUPER MICRO COMPUTER INC(SMCI)$ the swing in price is definitely not for the faint- hearted","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/335653259452592","isVote":1,"tweetType":1,"viewCount":270,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":276471951421464,"gmtCreate":1708528361605,"gmtModify":1708528365063,"author":{"id":"3585907907201082","authorId":"3585907907201082","name":"gfy","avatar":"https://static.tigerbbs.com/5a74f7299f0be4bc2af3a318ef1e85c4","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585907907201082","authorIdStr":"3585907907201082"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA Corp(NVDA)$&nbsp;</a><v-v data-views=\"1\"></v-v> &nbsp;AI is just starting, the potential is still at its infancy","listText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA Corp(NVDA)$&nbsp;</a><v-v data-views=\"1\"></v-v> &nbsp;AI is just starting, the potential is still at its infancy","text":"$NVIDIA Corp(NVDA)$ AI is just starting, the potential is still at its infancy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/276471951421464","isVote":1,"tweetType":1,"viewCount":389,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":860391947,"gmtCreate":1632131363289,"gmtModify":1676530706958,"author":{"id":"3585907907201082","authorId":"3585907907201082","name":"gfy","avatar":"https://static.tigerbbs.com/5a74f7299f0be4bc2af3a318ef1e85c4","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585907907201082","authorIdStr":"3585907907201082"},"themes":[],"htmlText":"interest seems like going to rise","listText":"interest seems like going to rise","text":"interest seems like going to rise","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/860391947","repostId":"1190902808","repostType":4,"repost":{"id":"1190902808","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1632128652,"share":"https://ttm.financial/m/news/1190902808?lang=&edition=fundamental","pubTime":"2021-09-20 17:04","market":"us","language":"en","title":"Futures fall over 1% on growth worries, focus turns to Fed","url":"https://stock-news.laohu8.com/highlight/detail?id=1190902808","media":"Reuters","summary":"Futures off: Dow 1.46%, S&P 1.23%, Nasdaq 1.05%.\n\nSept 20 (Reuters) - U.S. stock index futures fell ","content":"<ul>\n <li>Futures off: Dow 1.46%, S&amp;P 1.23%, Nasdaq 1.05%.</li>\n</ul>\n<p>Sept 20 (Reuters) - U.S. stock index futures fell 1% on Monday, as investors worried about rising COVID-19 cases and the pace of economic growth at the start of a week in which the Federal Reserve will decide on potentially tapering its massive pandemic-era stimulus.</p>\n<p>Futures tracking the blue-chip Dow index, which mainly comprises stocks reliant on a steady economic recovery, were down 1.5% by 04:31 a.m. ET.</p>\n<p>Wall Street's main indexes have been hurt this month by fears of potentially higher corporate tax rates denting earnings and have shrugged off signs inflation might have peaked. The benchmark S&amp;P 500 is on track to snap a seven-month gaining streak.</p>\n<p>All eyes on Wednesday will be on the Fed's policy meeting, where the central bank is expected to lay the groundwork for a tapering, although the consensus is for an actual announcement to be delayed until the November or December meetings.</p>\n<p>\"Anything pointing to a November tapering decision may support the U.S. dollar further and perhaps extend the latest setback in equities,\" said Charalambos Pissouros, head of research at JFD Group.</p>\n<p>\"Market participants may also be eager to find out whether this could also result in earlier rate hikes.\"</p>\n<p>Global equity markets have also been on edge recently over deepening troubles at China Evergrande, the world's most indebted property developer.</p>\n<p>Its shares sank more than 15% on Monday on worries about its ability to repay a small portion of its $305 billion debt due this Thursday.</p>\n<p>In the United States, S&amp;P 500 e-minis were down 1.23%, and Nasdaq 100 e-minis were down 1.05%.</p>\n<p>Economically sensitive industrials Boeing Co and Caterpillar Inc slipped 1.7% and 1.9%, respectively.</p>\n<p>Banking stocks including Morgan Stanley, JPMorgan Chase &amp; Co and Bank of America Corp fell between 1.8% and 2.7% in premarket trading, tracking U.S. Treasury yields.</p>\n<p>A slate of U.S.-listed Chinese stocks including Weibo Corp , Bilibili Inc, Vipshop Holdings Ltd and Pinduoduo Inc shed between 3.4% and 5.4% amid a widening regulatory crackdown in China.</p>\n<p>Heavyweight technology-related stocks , which have tended to perform better during times of economic uncertainty, were among the smallest decliners.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Futures fall over 1% on growth worries, focus turns to Fed</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFutures fall over 1% on growth worries, focus turns to Fed\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-09-20 17:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<ul>\n <li>Futures off: Dow 1.46%, S&amp;P 1.23%, Nasdaq 1.05%.</li>\n</ul>\n<p>Sept 20 (Reuters) - U.S. stock index futures fell 1% on Monday, as investors worried about rising COVID-19 cases and the pace of economic growth at the start of a week in which the Federal Reserve will decide on potentially tapering its massive pandemic-era stimulus.</p>\n<p>Futures tracking the blue-chip Dow index, which mainly comprises stocks reliant on a steady economic recovery, were down 1.5% by 04:31 a.m. ET.</p>\n<p>Wall Street's main indexes have been hurt this month by fears of potentially higher corporate tax rates denting earnings and have shrugged off signs inflation might have peaked. The benchmark S&amp;P 500 is on track to snap a seven-month gaining streak.</p>\n<p>All eyes on Wednesday will be on the Fed's policy meeting, where the central bank is expected to lay the groundwork for a tapering, although the consensus is for an actual announcement to be delayed until the November or December meetings.</p>\n<p>\"Anything pointing to a November tapering decision may support the U.S. dollar further and perhaps extend the latest setback in equities,\" said Charalambos Pissouros, head of research at JFD Group.</p>\n<p>\"Market participants may also be eager to find out whether this could also result in earlier rate hikes.\"</p>\n<p>Global equity markets have also been on edge recently over deepening troubles at China Evergrande, the world's most indebted property developer.</p>\n<p>Its shares sank more than 15% on Monday on worries about its ability to repay a small portion of its $305 billion debt due this Thursday.</p>\n<p>In the United States, S&amp;P 500 e-minis were down 1.23%, and Nasdaq 100 e-minis were down 1.05%.</p>\n<p>Economically sensitive industrials Boeing Co and Caterpillar Inc slipped 1.7% and 1.9%, respectively.</p>\n<p>Banking stocks including Morgan Stanley, JPMorgan Chase &amp; Co and Bank of America Corp fell between 1.8% and 2.7% in premarket trading, tracking U.S. Treasury yields.</p>\n<p>A slate of U.S.-listed Chinese stocks including Weibo Corp , Bilibili Inc, Vipshop Holdings Ltd and Pinduoduo Inc shed between 3.4% and 5.4% amid a widening regulatory crackdown in China.</p>\n<p>Heavyweight technology-related stocks , which have tended to perform better during times of economic uncertainty, were among the smallest decliners.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite","SPY":"标普500ETF",".DJI":"道琼斯",".SPX":"S&P 500 Index"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1190902808","content_text":"Futures off: Dow 1.46%, S&P 1.23%, Nasdaq 1.05%.\n\nSept 20 (Reuters) - U.S. stock index futures fell 1% on Monday, as investors worried about rising COVID-19 cases and the pace of economic growth at the start of a week in which the Federal Reserve will decide on potentially tapering its massive pandemic-era stimulus.\nFutures tracking the blue-chip Dow index, which mainly comprises stocks reliant on a steady economic recovery, were down 1.5% by 04:31 a.m. ET.\nWall Street's main indexes have been hurt this month by fears of potentially higher corporate tax rates denting earnings and have shrugged off signs inflation might have peaked. The benchmark S&P 500 is on track to snap a seven-month gaining streak.\nAll eyes on Wednesday will be on the Fed's policy meeting, where the central bank is expected to lay the groundwork for a tapering, although the consensus is for an actual announcement to be delayed until the November or December meetings.\n\"Anything pointing to a November tapering decision may support the U.S. dollar further and perhaps extend the latest setback in equities,\" said Charalambos Pissouros, head of research at JFD Group.\n\"Market participants may also be eager to find out whether this could also result in earlier rate hikes.\"\nGlobal equity markets have also been on edge recently over deepening troubles at China Evergrande, the world's most indebted property developer.\nIts shares sank more than 15% on Monday on worries about its ability to repay a small portion of its $305 billion debt due this Thursday.\nIn the United States, S&P 500 e-minis were down 1.23%, and Nasdaq 100 e-minis were down 1.05%.\nEconomically sensitive industrials Boeing Co and Caterpillar Inc slipped 1.7% and 1.9%, respectively.\nBanking stocks including Morgan Stanley, JPMorgan Chase & Co and Bank of America Corp fell between 1.8% and 2.7% in premarket trading, tracking U.S. Treasury yields.\nA slate of U.S.-listed Chinese stocks including Weibo Corp , Bilibili Inc, Vipshop Holdings Ltd and Pinduoduo Inc shed between 3.4% and 5.4% amid a widening regulatory crackdown in China.\nHeavyweight technology-related stocks , which have tended to perform better during times of economic uncertainty, were among the smallest decliners.","news_type":1},"isVote":1,"tweetType":1,"viewCount":402,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":259550668578984,"gmtCreate":1704377401513,"gmtModify":1704377405467,"author":{"id":"3585907907201082","authorId":"3585907907201082","name":"gfy","avatar":"https://static.tigerbbs.com/5a74f7299f0be4bc2af3a318ef1e85c4","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585907907201082","authorIdStr":"3585907907201082"},"themes":[],"htmlText":"Thanks for the opportunity to get richer in the new year!","listText":"Thanks for the opportunity to get richer in the new year!","text":"Thanks for the opportunity to get richer in the new year!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/259550668578984","isVote":1,"tweetType":1,"viewCount":110,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9003839874,"gmtCreate":1640920770106,"gmtModify":1676533555414,"author":{"id":"3585907907201082","authorId":"3585907907201082","name":"gfy","avatar":"https://static.tigerbbs.com/5a74f7299f0be4bc2af3a318ef1e85c4","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585907907201082","authorIdStr":"3585907907201082"},"themes":[],"htmlText":"Unlike Uber and Gojek, Grab does not have the first-mover advantage, wouldn't&nbsp; you agree?","listText":"Unlike Uber and Gojek, Grab does not have the first-mover advantage, wouldn't&nbsp; you agree?","text":"Unlike Uber and Gojek, Grab does not have the first-mover advantage, wouldn't you agree?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9003839874","repostId":"1122789395","repostType":2,"repost":{"id":"1122789395","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640682350,"share":"https://ttm.financial/m/news/1122789395?lang=&edition=fundamental","pubTime":"2021-12-28 17:05","market":"us","language":"en","title":"Grab stock climbed more than 3% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1122789395","media":"Tiger Newspress","summary":"Grab stock climbed more than 3% in premarket trading Tuesday after falling more than 3% yesterday.\n\n","content":"<p>Grab stock climbed more than 3% in premarket trading&nbsp;Tuesday&nbsp;after falling more than 3% yesterday.</p>\n<p><img src=\"https://static.tigerbbs.com/7dfb400a3587d9cc0fba919a211e18a3\" tg-width=\"841\" tg-height=\"618\" referrerpolicy=\"no-referrer\"></p>\n<p>Grab debuted on the Nasdaq following a deal with blank-check company&nbsp;Altimeter Growth Corp., which&nbsp;valued the company at nearly $40 billion. It became the largest-ever company to close a SPAC merger and go public.</p>\n<p>But shares fell more than 20% from $13.06 to $8.75 a piece in the first day of trading. Since then, the stock has fallen another 16%.</p>\n<p>Still, JPMorgan likes the stock and said the company has a “superior regional superapp” and multiple opportunities for “multi-year growth.” The investment bank said that Grab’s regional leadership in Southeast Asia is driven by a highly scalable and localized platform that is underpinned by its proprietary technology.</p>\n<p>“The platform enables Grab to offer its services at a structurally lower cost base vs peers, with higher retention rates,” JPMorgan analysts wrote in their initiation coverage note earlier this month. “Grab’s platform gives it further advantages over its peers with limited geographical presence and/or fewer services, as Grab can allocate cash flows across countries and services to deliver on growth.”</p>\n<p>Here are JPMorgan, Citi and Evercore’s ratings and price targets for Grab, and why they like the stock:</p>\n<p><b>JPMorgan</b></p>\n<p>JPMorgan initiated coverage on Grab with an overweight rating and a price target of $12.50 over the next 12 months — that represents over 70% upside from the Dec. 23 closing price of $7.35.</p>\n<p>Based on the investment bank’s rating system, an overweight rating implies JPMorgan expects Grab’s stock to outperform over the next six to 12 months.</p>\n<p>The analysts said Grab’s superior regional app, comprising multiple services including ride-hailing and food delivery, is “best geared to rising online consumption” in Southeast Asia. They said they identified gross merchandize value and revenue growth as key catalysts for the company and they see “multiple opportunities for multi-year growth.”</p>\n<p>GMV is a metric&nbsp;often used in e-commerce&nbsp;to measure the total dollar value of goods sold&nbsp;over a certain period of time.</p>\n<p>The investment bank said Grab is a leader in ride-hailing across the region and that could lead to a highly profitable mobility business, where lifting Covid restrictions and broader economic reopening could drive growth.</p>\n<p>While the company’s delivery business is at an earlier stage of development, JPMorgan said there’s growth potential due to the relatively fragmented, but large total addressable market for food delivery and groceries. But the bank said that Grab is likely to see losses in the near-to-mid term due to investments and competition for market share.</p>\n<p>The analysts warned, however, that Grab’s stock price could be volatile over the next six months as the free float expands due to staggered expiration of lock-ups that will release additional shares. Potential inclusion in MSCI indexes could also contribute to the volatility, JPMorgan said.</p>\n<p><b>Citi</b></p>\n<p>Citi initiated coverage of Grab with a buy rating and a price target of $12 a share, but also flagged the stock as high risk.</p>\n<p>Compared with regional peers, Citi analysts said Grab benefits from its ability to capture larger volumes of consumer data given higher frequency of delivery and mobility demand compared to services like e-commerce. That gives the company an easier way to cross-sell its financial services products, they added.</p>\n<p>The analysts pointed out that Grab has a “broader geographic footprint with more equal strength in the ... Southeast Asia countries in which it operates,” compared with Indonesian rival GoTo Group.</p>\n<p>Citi said, however, spending per transaction and per user is lower for Grab than other regional players like&nbsp;Sea, which operates e-commerce platform Shopee. That implies Grab would face more headwinds if Covid cases in the region surge again, forcing countries to impose lockdowns and other mobility restrictions.</p>\n<p>“Grab also lacks a high-margin gaming business and global exposure given its Southeast Asia focus,” Citi analysts said.</p>\n<p><b>Evercore</b></p>\n<p>Evercore initiated coverage with an outperform rating and a price target of $10.</p>\n<p>The firm said Grab will likely face more local competition in each market for its delivery business compared to ridesharing, where the only other international incumbent is GoTo Group’s Gojek — particularly, in Indonesia.</p>\n<p>“Within its Delivery segment, Grab faces a bit more competition across its core geographies,” Evercore analysts said in a recent note. They flagged the likes of Foodpanda, Gojek and Deliveroo in Singapore, LineMan in Thailand as well as Now and Baemin in Vietnam as competitors.</p>\n<p>“Lastly, Grab competes with last-mile logistics providers such as Gojek and Lalamove, and more local last-mile players such as AhaMove (Vietnam),” the analysts said.</p>\n<p>In the financial services business, Grab faces competition from traditional players including credit card companies, banks as well as cash, which is still the predominant mode of payment in Southeast Asia.</p>\n<p>Still, the Evercore analysts said that most of Grab’s core business segments including delivery, mobility and financial services remain underpenetrated, which grants the Singapore-headquartered company “a probable long runway for growth.”</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Grab stock climbed more than 3% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGrab stock climbed more than 3% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-28 17:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Grab stock climbed more than 3% in premarket trading&nbsp;Tuesday&nbsp;after falling more than 3% yesterday.</p>\n<p><img src=\"https://static.tigerbbs.com/7dfb400a3587d9cc0fba919a211e18a3\" tg-width=\"841\" tg-height=\"618\" referrerpolicy=\"no-referrer\"></p>\n<p>Grab debuted on the Nasdaq following a deal with blank-check company&nbsp;Altimeter Growth Corp., which&nbsp;valued the company at nearly $40 billion. It became the largest-ever company to close a SPAC merger and go public.</p>\n<p>But shares fell more than 20% from $13.06 to $8.75 a piece in the first day of trading. Since then, the stock has fallen another 16%.</p>\n<p>Still, JPMorgan likes the stock and said the company has a “superior regional superapp” and multiple opportunities for “multi-year growth.” The investment bank said that Grab’s regional leadership in Southeast Asia is driven by a highly scalable and localized platform that is underpinned by its proprietary technology.</p>\n<p>“The platform enables Grab to offer its services at a structurally lower cost base vs peers, with higher retention rates,” JPMorgan analysts wrote in their initiation coverage note earlier this month. “Grab’s platform gives it further advantages over its peers with limited geographical presence and/or fewer services, as Grab can allocate cash flows across countries and services to deliver on growth.”</p>\n<p>Here are JPMorgan, Citi and Evercore’s ratings and price targets for Grab, and why they like the stock:</p>\n<p><b>JPMorgan</b></p>\n<p>JPMorgan initiated coverage on Grab with an overweight rating and a price target of $12.50 over the next 12 months — that represents over 70% upside from the Dec. 23 closing price of $7.35.</p>\n<p>Based on the investment bank’s rating system, an overweight rating implies JPMorgan expects Grab’s stock to outperform over the next six to 12 months.</p>\n<p>The analysts said Grab’s superior regional app, comprising multiple services including ride-hailing and food delivery, is “best geared to rising online consumption” in Southeast Asia. They said they identified gross merchandize value and revenue growth as key catalysts for the company and they see “multiple opportunities for multi-year growth.”</p>\n<p>GMV is a metric&nbsp;often used in e-commerce&nbsp;to measure the total dollar value of goods sold&nbsp;over a certain period of time.</p>\n<p>The investment bank said Grab is a leader in ride-hailing across the region and that could lead to a highly profitable mobility business, where lifting Covid restrictions and broader economic reopening could drive growth.</p>\n<p>While the company’s delivery business is at an earlier stage of development, JPMorgan said there’s growth potential due to the relatively fragmented, but large total addressable market for food delivery and groceries. But the bank said that Grab is likely to see losses in the near-to-mid term due to investments and competition for market share.</p>\n<p>The analysts warned, however, that Grab’s stock price could be volatile over the next six months as the free float expands due to staggered expiration of lock-ups that will release additional shares. Potential inclusion in MSCI indexes could also contribute to the volatility, JPMorgan said.</p>\n<p><b>Citi</b></p>\n<p>Citi initiated coverage of Grab with a buy rating and a price target of $12 a share, but also flagged the stock as high risk.</p>\n<p>Compared with regional peers, Citi analysts said Grab benefits from its ability to capture larger volumes of consumer data given higher frequency of delivery and mobility demand compared to services like e-commerce. That gives the company an easier way to cross-sell its financial services products, they added.</p>\n<p>The analysts pointed out that Grab has a “broader geographic footprint with more equal strength in the ... Southeast Asia countries in which it operates,” compared with Indonesian rival GoTo Group.</p>\n<p>Citi said, however, spending per transaction and per user is lower for Grab than other regional players like&nbsp;Sea, which operates e-commerce platform Shopee. That implies Grab would face more headwinds if Covid cases in the region surge again, forcing countries to impose lockdowns and other mobility restrictions.</p>\n<p>“Grab also lacks a high-margin gaming business and global exposure given its Southeast Asia focus,” Citi analysts said.</p>\n<p><b>Evercore</b></p>\n<p>Evercore initiated coverage with an outperform rating and a price target of $10.</p>\n<p>The firm said Grab will likely face more local competition in each market for its delivery business compared to ridesharing, where the only other international incumbent is GoTo Group’s Gojek — particularly, in Indonesia.</p>\n<p>“Within its Delivery segment, Grab faces a bit more competition across its core geographies,” Evercore analysts said in a recent note. They flagged the likes of Foodpanda, Gojek and Deliveroo in Singapore, LineMan in Thailand as well as Now and Baemin in Vietnam as competitors.</p>\n<p>“Lastly, Grab competes with last-mile logistics providers such as Gojek and Lalamove, and more local last-mile players such as AhaMove (Vietnam),” the analysts said.</p>\n<p>In the financial services business, Grab faces competition from traditional players including credit card companies, banks as well as cash, which is still the predominant mode of payment in Southeast Asia.</p>\n<p>Still, the Evercore analysts said that most of Grab’s core business segments including delivery, mobility and financial services remain underpenetrated, which grants the Singapore-headquartered company “a probable long runway for growth.”</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GRAB":"Grab Holdings"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1122789395","content_text":"Grab stock climbed more than 3% in premarket trading Tuesday after falling more than 3% yesterday.\n\nGrab debuted on the Nasdaq following a deal with blank-check company Altimeter Growth Corp., which valued the company at nearly $40 billion. It became the largest-ever company to close a SPAC merger and go public.\nBut shares fell more than 20% from $13.06 to $8.75 a piece in the first day of trading. Since then, the stock has fallen another 16%.\nStill, JPMorgan likes the stock and said the company has a “superior regional superapp” and multiple opportunities for “multi-year growth.” The investment bank said that Grab’s regional leadership in Southeast Asia is driven by a highly scalable and localized platform that is underpinned by its proprietary technology.\n“The platform enables Grab to offer its services at a structurally lower cost base vs peers, with higher retention rates,” JPMorgan analysts wrote in their initiation coverage note earlier this month. “Grab’s platform gives it further advantages over its peers with limited geographical presence and/or fewer services, as Grab can allocate cash flows across countries and services to deliver on growth.”\nHere are JPMorgan, Citi and Evercore’s ratings and price targets for Grab, and why they like the stock:\nJPMorgan\nJPMorgan initiated coverage on Grab with an overweight rating and a price target of $12.50 over the next 12 months — that represents over 70% upside from the Dec. 23 closing price of $7.35.\nBased on the investment bank’s rating system, an overweight rating implies JPMorgan expects Grab’s stock to outperform over the next six to 12 months.\nThe analysts said Grab’s superior regional app, comprising multiple services including ride-hailing and food delivery, is “best geared to rising online consumption” in Southeast Asia. They said they identified gross merchandize value and revenue growth as key catalysts for the company and they see “multiple opportunities for multi-year growth.”\nGMV is a metric often used in e-commerce to measure the total dollar value of goods sold over a certain period of time.\nThe investment bank said Grab is a leader in ride-hailing across the region and that could lead to a highly profitable mobility business, where lifting Covid restrictions and broader economic reopening could drive growth.\nWhile the company’s delivery business is at an earlier stage of development, JPMorgan said there’s growth potential due to the relatively fragmented, but large total addressable market for food delivery and groceries. But the bank said that Grab is likely to see losses in the near-to-mid term due to investments and competition for market share.\nThe analysts warned, however, that Grab’s stock price could be volatile over the next six months as the free float expands due to staggered expiration of lock-ups that will release additional shares. Potential inclusion in MSCI indexes could also contribute to the volatility, JPMorgan said.\nCiti\nCiti initiated coverage of Grab with a buy rating and a price target of $12 a share, but also flagged the stock as high risk.\nCompared with regional peers, Citi analysts said Grab benefits from its ability to capture larger volumes of consumer data given higher frequency of delivery and mobility demand compared to services like e-commerce. That gives the company an easier way to cross-sell its financial services products, they added.\nThe analysts pointed out that Grab has a “broader geographic footprint with more equal strength in the ... Southeast Asia countries in which it operates,” compared with Indonesian rival GoTo Group.\nCiti said, however, spending per transaction and per user is lower for Grab than other regional players like Sea, which operates e-commerce platform Shopee. That implies Grab would face more headwinds if Covid cases in the region surge again, forcing countries to impose lockdowns and other mobility restrictions.\n“Grab also lacks a high-margin gaming business and global exposure given its Southeast Asia focus,” Citi analysts said.\nEvercore\nEvercore initiated coverage with an outperform rating and a price target of $10.\nThe firm said Grab will likely face more local competition in each market for its delivery business compared to ridesharing, where the only other international incumbent is GoTo Group’s Gojek — particularly, in Indonesia.\n“Within its Delivery segment, Grab faces a bit more competition across its core geographies,” Evercore analysts said in a recent note. They flagged the likes of Foodpanda, Gojek and Deliveroo in Singapore, LineMan in Thailand as well as Now and Baemin in Vietnam as competitors.\n“Lastly, Grab competes with last-mile logistics providers such as Gojek and Lalamove, and more local last-mile players such as AhaMove (Vietnam),” the analysts said.\nIn the financial services business, Grab faces competition from traditional players including credit card companies, banks as well as cash, which is still the predominant mode of payment in Southeast Asia.\nStill, the Evercore analysts said that most of Grab’s core business segments including delivery, mobility and financial services remain underpenetrated, which grants the Singapore-headquartered company “a probable long runway for growth.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":480,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9003897561,"gmtCreate":1640920473781,"gmtModify":1676533555373,"author":{"id":"3585907907201082","authorId":"3585907907201082","name":"gfy","avatar":"https://static.tigerbbs.com/5a74f7299f0be4bc2af3a318ef1e85c4","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585907907201082","authorIdStr":"3585907907201082"},"themes":[],"htmlText":"Nice analysis! Unfortunately all of us can only wish we had a crystal ball, right?","listText":"Nice analysis! Unfortunately all of us can only wish we had a crystal ball, right?","text":"Nice analysis! Unfortunately all of us can only wish we had a crystal ball, right?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9003897561","repostId":"2195932414","repostType":2,"repost":{"id":"2195932414","pubTimestamp":1640793600,"share":"https://ttm.financial/m/news/2195932414?lang=&edition=fundamental","pubTime":"2021-12-30 00:00","market":"us","language":"en","title":"If You Invested $10,000 in Novavax in 2020, This Is How Much You Would Have Today","url":"https://stock-news.laohu8.com/highlight/detail?id=2195932414","media":"Motley Fool","summary":"Your returns could range between a loss and more than 3,000% depending on which month you invested in.","content":"<html><body><span>\n<p><strong>Novavax </strong><span>(NASDAQ:NVAX)</span> has been a volatile stock over the past few years. From optimism around its COVID-19 vaccine to concerns about delays, it has sent its investors on a roller-coaster ride. Early investors are sitting on some incredible returns right now, but those who bought early on this year when the stock was trading at more than $300 have incurred steep losses.</p>\n<p>I'll look back at how you would have done in 2020 if you had bought at different months, and how early you would have needed to get in on the stock to earn a great return. And, most importantly, I'll assess whether the stock worth buying today.</p>\n<div><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F658847%2Ftwo-scientists-reviewing-a-sample-in-a-tube.jpg&amp;w=700&amp;op=resize\" srcset=\"https://g.foolcdn.com/image/?url=https%3A//g.foolcdn.com/editorial/images/658847/two-scientists-reviewing-a-sample-in-a-tube.jpg&amp;w=300&amp;op=resize 300w, https://g.foolcdn.com/image/?url=https%3A//g.foolcdn.com/editorial/images/658847/two-scientists-reviewing-a-sample-in-a-tube.jpg&amp;w=1000&amp;op=resize 1000w, https://g.foolcdn.com/image/?url=https%3A//g.foolcdn.com/editorial/images/658847/two-scientists-reviewing-a-sample-in-a-tube.jpg&amp;w=2000&amp;op=resize 2000w\"/>\n<p>Image source: Getty Images</p>\n</div>\n<h2>How early would have been early enough in 2020?</h2>\n<p>Here's a look at Novavax's share price at the start of each month of 2020, how many shares you could have bought with a $10,000 investment, and what the value of it would be today. </p>\n<div><table width=\"426\">\n<thead>\n<tr>\n<th>Month</th>\n<th>Closing Price</th>\n<th>Shares Bought</th>\n<th>Approximate Value Today</th>\n<th>Return</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>January</td>\n<td>$4.49</td>\n<td>2,227.2</td>\n<td> $351,448</td>\n<td>3,414%</td>\n</tr>\n<tr>\n<td>February</td>\n<td>$6.81</td>\n<td>1,468.4</td>\n<td> $231,718</td>\n<td>2,217%</td>\n</tr>\n<tr>\n<td>March</td>\n<td>$12.02</td>\n<td>831.9</td>\n<td> $131,281</td>\n<td>1,213%</td>\n</tr>\n<tr>\n<td>April</td>\n<td>$14.03</td>\n<td>712.8</td>\n<td> $112,473</td>\n<td>1,025%</td>\n</tr>\n<tr>\n<td>May</td>\n<td>$17.33</td>\n<td>577.0</td>\n<td> $91,056</td>\n<td>811%</td>\n</tr>\n<tr>\n<td>June</td>\n<td>$52.82</td>\n<td>189.3</td>\n<td> $29,875</td>\n<td>199%</td>\n</tr>\n<tr>\n<td>July</td>\n<td>$79.70</td>\n<td>125.5</td>\n<td> $19,799</td>\n<td>98%</td>\n</tr>\n<tr>\n<td>August</td>\n<td>$155.87</td>\n<td>64.2</td>\n<td> $10,124</td>\n<td>1%</td>\n</tr>\n<tr>\n<td>September</td>\n<td>$105.08</td>\n<td>95.2</td>\n<td> $15,017</td>\n<td>50%</td>\n</tr>\n<tr>\n<td>October</td>\n<td>$104.90</td>\n<td>95.3</td>\n<td> $15,043</td>\n<td>50%</td>\n</tr>\n<tr>\n<td>November</td>\n<td>$82.40</td>\n<td>121.4</td>\n<td> $19,150</td>\n<td>92%</td>\n</tr>\n<tr>\n<td>December</td>\n<td>$123.47</td>\n<td>81.0</td>\n<td> $12,780</td>\n<td>28%</td>\n</tr>\n</tbody>\n</table></div>\n<p>Data source: Yahoo! Finance.</p>\n<p>Investing at the start of January would have netted the best return, at a whopping 3,414%. It was late February that the healthcare company announced it was advancing development of its COVID-19 vaccine and that phase 1 trials would commence in the coming months. If you had the foresight to bet on the company at that point, it would have been a tremendous gamble; it wasn't until March that the World Health Organization (WHO) even declared the coronavirus a pandemic. The company was also coming off a year in which it generated just $19 million in revenue (mainly through grants and government contracts) and incurred a loss of $133 million.</p><div></div>\n<p>April presented a more realistic time when the risk-reward ratio became more tenable. At that point, the pandemic was here and Novavax had announced the previous month that it would be receiving $4 million in funding from the Coalition for Epidemic Preparedness Innovations (CEPI) to help with the development of the vaccine. In May, CEPI would add another $384 million to that funding. Before the end of the month, the company enrolled its first participants in its phase 1/2 trial. By the start of June, shares were already up over $50. If you waited until then, your investment would have tripled in value.</p>\n<p>And if you waited until December, the stock would be up to $123. Later in the month, the U.S. Food and Drug Administration would issue Emergency Use Authorizations (EUAs) for vaccines from <strong>Pfizer</strong> and <strong>Moderna. </strong>The authorization for <strong>Johnson &amp; Johnson</strong>'s vaccine would come in February 2021. </p>\n<h2>Is Novavax a good buy today?</h2>\n<p>It has been more than a year since the EUAs came in for Moderna and Pfizer's vaccines. More than 60% of the U.S. population is fully vaccinated and many people are on their way to receiving their booster shots. Novavax could apply for an EUA any day now, and investors may be getting unnerved by the lack of progress and constant delays. </p>\n<p>But even if it doesn't obtain an EUA in the U.S., there's arguably much more of a need to fill in other parts of the world, especially in countries where vaccination rates are significantly lower. The downside is that Novavax might not fetch as high a price for its vaccine, but it would still generate revenue nonetheless. In November, Novavax received EUAs from the Philippines and Indonesia for its vaccine, and it has applied for approvals in other countries as well. On Dec. 17, the World Health Organization added the vaccine to its Emergency Use Listing, potentially paving the way for Novavax's vaccine to get exported to even more countries.</p><div></div>\n<p>It's safe to say that Novavax will generate COVID-19-related revenue, but whether it will be enough to support its current valuation is the bigger question at this point. At a forward price-to-sales (P/S) multiple of more than eight, it's priced higher than the other vaccine makers mentioned earlier:</p>\n<p><img src=\"https://media.ycharts.com/charts/b277bae638c59f4fa45bd391dcd8f9c7.png\"/></p>\n<p>NVAX PS Ratio (Forward) data by YCharts</p>\n<p>Novavax has taken a long time to get to where it is today, which is well behind the leaders in the COVID-19 vaccine market at this point. And based on that track record, I wouldn't take a chance on a stock that has created a bit of reputation for delays and disappointing investors. At this stage, there may be more risk than there is reward, and that's why I'd avoid Novavax stock for now.</p>\n<div></div>\n</span></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>If You Invested $10,000 in Novavax in 2020, This Is How Much You Would Have Today</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIf You Invested $10,000 in Novavax in 2020, This Is How Much You Would Have Today\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-30 00:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/30/if-you-invested-10000-in-novavax-in-2020-this-is-h/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Novavax (NASDAQ:NVAX) has been a volatile stock over the past few years. From optimism around its COVID-19 vaccine to concerns about delays, it has sent its investors on a roller-coaster ride. Early ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/30/if-you-invested-10000-in-novavax-in-2020-this-is-h/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药","BK4568":"美国抗疫概念","BK4139":"生物科技"},"source_url":"https://www.fool.com/investing/2021/12/30/if-you-invested-10000-in-novavax-in-2020-this-is-h/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2195932414","content_text":"Novavax (NASDAQ:NVAX) has been a volatile stock over the past few years. From optimism around its COVID-19 vaccine to concerns about delays, it has sent its investors on a roller-coaster ride. Early investors are sitting on some incredible returns right now, but those who bought early on this year when the stock was trading at more than $300 have incurred steep losses.\nI'll look back at how you would have done in 2020 if you had bought at different months, and how early you would have needed to get in on the stock to earn a great return. And, most importantly, I'll assess whether the stock worth buying today.\n\nImage source: Getty Images\n\nHow early would have been early enough in 2020?\nHere's a look at Novavax's share price at the start of each month of 2020, how many shares you could have bought with a $10,000 investment, and what the value of it would be today. \n\n\n\nMonth\nClosing Price\nShares Bought\nApproximate Value Today\nReturn\n\n\n\n\nJanuary\n$4.49\n2,227.2\n $351,448\n3,414%\n\n\nFebruary\n$6.81\n1,468.4\n $231,718\n2,217%\n\n\nMarch\n$12.02\n831.9\n $131,281\n1,213%\n\n\nApril\n$14.03\n712.8\n $112,473\n1,025%\n\n\nMay\n$17.33\n577.0\n $91,056\n811%\n\n\nJune\n$52.82\n189.3\n $29,875\n199%\n\n\nJuly\n$79.70\n125.5\n $19,799\n98%\n\n\nAugust\n$155.87\n64.2\n $10,124\n1%\n\n\nSeptember\n$105.08\n95.2\n $15,017\n50%\n\n\nOctober\n$104.90\n95.3\n $15,043\n50%\n\n\nNovember\n$82.40\n121.4\n $19,150\n92%\n\n\nDecember\n$123.47\n81.0\n $12,780\n28%\n\n\n\nData source: Yahoo! Finance.\nInvesting at the start of January would have netted the best return, at a whopping 3,414%. It was late February that the healthcare company announced it was advancing development of its COVID-19 vaccine and that phase 1 trials would commence in the coming months. If you had the foresight to bet on the company at that point, it would have been a tremendous gamble; it wasn't until March that the World Health Organization (WHO) even declared the coronavirus a pandemic. The company was also coming off a year in which it generated just $19 million in revenue (mainly through grants and government contracts) and incurred a loss of $133 million.\nApril presented a more realistic time when the risk-reward ratio became more tenable. At that point, the pandemic was here and Novavax had announced the previous month that it would be receiving $4 million in funding from the Coalition for Epidemic Preparedness Innovations (CEPI) to help with the development of the vaccine. In May, CEPI would add another $384 million to that funding. Before the end of the month, the company enrolled its first participants in its phase 1/2 trial. By the start of June, shares were already up over $50. If you waited until then, your investment would have tripled in value.\nAnd if you waited until December, the stock would be up to $123. Later in the month, the U.S. Food and Drug Administration would issue Emergency Use Authorizations (EUAs) for vaccines from Pfizer and Moderna. The authorization for Johnson & Johnson's vaccine would come in February 2021. \nIs Novavax a good buy today?\nIt has been more than a year since the EUAs came in for Moderna and Pfizer's vaccines. More than 60% of the U.S. population is fully vaccinated and many people are on their way to receiving their booster shots. Novavax could apply for an EUA any day now, and investors may be getting unnerved by the lack of progress and constant delays. \nBut even if it doesn't obtain an EUA in the U.S., there's arguably much more of a need to fill in other parts of the world, especially in countries where vaccination rates are significantly lower. The downside is that Novavax might not fetch as high a price for its vaccine, but it would still generate revenue nonetheless. In November, Novavax received EUAs from the Philippines and Indonesia for its vaccine, and it has applied for approvals in other countries as well. On Dec. 17, the World Health Organization added the vaccine to its Emergency Use Listing, potentially paving the way for Novavax's vaccine to get exported to even more countries.\nIt's safe to say that Novavax will generate COVID-19-related revenue, but whether it will be enough to support its current valuation is the bigger question at this point. At a forward price-to-sales (P/S) multiple of more than eight, it's priced higher than the other vaccine makers mentioned earlier:\n\nNVAX PS Ratio (Forward) data by YCharts\nNovavax has taken a long time to get to where it is today, which is well behind the leaders in the COVID-19 vaccine market at this point. And based on that track record, I wouldn't take a chance on a stock that has created a bit of reputation for delays and disappointing investors. At this stage, there may be more risk than there is reward, and that's why I'd avoid Novavax stock for now.","news_type":1},"isVote":1,"tweetType":1,"viewCount":327,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}